Literature DB >> 19839494

Urticarial vasculitis: etiologies and clinical course.

Kanokvalai Kulthanan1, Meethawee Cheepsomsong, Sukhum Jiamton.   

Abstract

Out of 64 patients diagnosed with urticarial vasculitis (UV), 49 (76.6%) presented with their first attack of UV. The others experienced recurrent attacks with a mean number of 3.3 past recurrences. Fifteen patients had angioedema (23.4%) and 16 (25%) suffered systemic involvement. The most common abnormal laboratory finding was an increased erythrocyte sedimentation rate. Six of 62 patients (9.7%) had decreased C3 levels. A cause could be identified in 19 patients (29.7%). The most common identified cause was infection; other causes included drugs, malignancy and systemic lupus erythematosus (SLE). The prevalence of immunoreactant deposits in the skin lesions measured by DIF was 54.7% (35 of 64 patients). The median disease duration of each episode was 85 days. The probability that patients were free of symptoms within one year was 70%. Patients with an idiopathic cause had a statistically significant longer course duration of each episode than the group with upper respiratory tract infection. Compared to reports from Westem countries, our patients seemed to have less severe symptoms and a lower percentage of hypocomplementemic UV and SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839494

Source DB:  PubMed          Journal:  Asian Pac J Allergy Immunol        ISSN: 0125-877X            Impact factor:   2.310


  8 in total

1.  Florid urticarial vasculitis heralding a flare up of ulcerative colitis.

Authors:  Evon Boules; Calum Lyon
Journal:  BMJ Case Rep       Date:  2014-12-22

2.  A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria.

Authors:  Viktoria Puhl; Hanna Bonnekoh; Jörg Scheffel; Tomasz Hawro; Karsten Weller; Peter von den Driesch; Hans-Joachim Röwert-Huber; José Cardoso; Margarida Gonçalo; Marcus Maurer; Karoline Krause
Journal:  Clin Transl Allergy       Date:  2021-04       Impact factor: 5.871

3.  Clinical characteristics and treatment outcomes in patients with urticarial vasculitis.

Authors:  Gamze Serarslan; Ebru Okyay
Journal:  North Clin Istanb       Date:  2020-08-08

Review 4.  Pathophysiological Relationship between Infections and Systemic Vasculitis.

Authors:  Carolina Muñoz-Grajales; Juan C Pineda
Journal:  Autoimmune Dis       Date:  2015-07-07

5.  Urticarial vasculitis in northern Spain: clinical study of 21 cases.

Authors:  Javier Loricera; Vanesa Calvo-Río; Cristina Mata; Francisco Ortiz-Sanjuán; Marcos A González-López; Lino Alvarez; M Carmen González-Vela; Susana Armesto; Héctor Fernández-Llaca; Javier Rueda-Gotor; Miguel A González-Gay; Ricardo Blanco
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

6.  Telmisartan induced urticarial vasculitis.

Authors:  Vikram K Mahajan; Ravinder Singh; Mrinal Gupta; Rashmi Raina
Journal:  Indian J Pharmacol       Date:  2015 Sep-Oct       Impact factor: 1.200

7.  Development of a clinical-dermoscopic model for the diagnosis of urticarial vasculitis.

Authors:  B García-García; J Aubán-Pariente; P Munguía-Calzada; B Vivanco; G Argenziano; F Vázquez-López
Journal:  Sci Rep       Date:  2020-04-08       Impact factor: 4.379

8.  Management of urticarial vasculitis: A worldwide physician perspective.

Authors:  Pavel Kolkhir; Hanna Bonnekoh; Emek Kocatürk; Michihiro Hide; Martin Metz; Mario Sánchez-Borges; Karoline Krause; Marcus Maurer
Journal:  World Allergy Organ J       Date:  2020-03-05       Impact factor: 4.084

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.